This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Affymetrix this week said it expects fourth-quarter revenue to decline around 11.5 percent as it begins a limited launch of its single-chip SNP 5.0 array but delays by around three months the release of its two-chip, 1 million SNP product.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.